AGENDA
(Oncology - March 2021)
MONDAY, MARCH 29, 2021
All Times are EST Time Zone
9:10am // OPENING REMARKS
9:20am // KEYNOTE TALK - BIDEN'S CANCER POLICY
Greg Simon (Former Executive Director Biden Cancer Initiative, Former Executive Director White House Moonshot, Former Director Domestic
Policy for Al Gore, Fmr Director of Global Public Affairs for Pfizer)
9:50am // Corporate Presentation - PharmAbcine
10:10am // Corporate Presentation - Pleco Therapeutics
10:30am // Corporate Presentation - Telexos
10:50am // Corporate Presentation - Heidelberg Pharma
11:10am // Corporate Presentation - Vivan Therapeutics
11:30am // Corporate Presentation - Katena Oncology
11:50am // Corporate Presentation - Cogen Bioscience
12:10pm // Corporate Presentation - Seneca Therapeutics
12:30pm // Corporate Presentation - Immunicom
12:50pm // INVESTOR PANEL
Moderator: William Werkmeister (Partner, OIP | Advisory Board, NFCR)
Richard Lipkin (Partner, Catalytic Impact Fund | Former Partner, Easton Capital)
Anton Gopka (Partner, ATEM Capital | NCI Venture Advisory Board)
Sal Buscemi (Founder, Dandrew Partners Encore Ventures FO)
1:20 pm // Corporate Presentation - Relevant Biosciences
1:40pm // Corporate Presentation - Actinium Pharmaceuticals (ATNM)
2:00pm // Corporate Presentation - Genprex (GNPX)
2:20pm // Corporate Presentation - SIWA Therapeutics
2:40pm // Corporate Presentation - Avidea Technologies
3:00pm // Corporate Presentation - RubrYc Therapeutics
3:20pm // Corporate Presentation - Filtricine
3:40pm // Corporate Presentation - BioEclipse Therapeutics
4:00pm // Corporate Presentation - NanoView Biosciences
4:20pm // Corporate Presentation - Ascentage Pharma
4:40pm // Corporate Presentation - Imagion Biosystems
5:00pm // TALK - NATIONAL FOUNDATION FOR CANCER RESEARCH - REVIEW OF NFCR FUNDING OPTIONS AND $1MILLION WOMEN'S VENTURE
COMPETITION
Rose Wang, Board Member of NFCR AIM-HI Women's Venture Competition
5:30pm // CLOSING REMARKS
TUESDAY, MARCH 30, 2021
All Times are EST Time Zone
8:50am // OPENING REMARKS - COVID SESSION
9:00am // KEYNOTE TALK - THE EFFICACY OF COVID-19 VACCINES
Dr. Jerome Kim (Director-General, International Vaccine Institute)
9:30am // TALK - VACCINE HESITANCY
Dr. Heidi Larson (Founding Director of the Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine
Former Director of Global Immunization Communication at UNICEF
Professor of Anthropology, Risk and Decision Science
Author of STUCK: How Vaccine Rumors Start – and Why They Don’t Go Away)
10:00am // Corporate Presentation - FSD BioSciences (HUGE)
10:20am // Corporate Presentation - Maxwell Biosciences
10:40am // Corporate Presentation - CytoAgents
11:00am // TALK - REVIEW OF EVIDENCE REGARDING IVERMECTIN FOR THE TREATMENT OF COVID-19
Dr. Paul Marik (Chief, Division of Pulmonary and Critical Care Medicine at Eastern Virginia Medical School)
11:30am // Corporate Presentation - Tactical Therapeutics
11:50am // Corporate Presentation - Cytocom
12:10pm // Corporate Presentation - SciTech Development
12:30pm // TALK - PARTNERING FOR VALUE: TECHNOLOGY TRANSFER AT NIAID
Dr. Wade Green (Team Lead, Technology Transfer & Intellectual Property Office (TTIPO)
National Institute of Allergy and Infectious Diseases (NIAID)
1:00pm // LUNCH PANEL - T-CELL THERAPY PANEL
Moderator: William Werkmeister (Partner, OIP Partners, /Advisory Board, National Foundation for Cancer Research)
Panelist: Alfred Slanetz (CEO, Geneius Biotech, Former CEO, Bluebird Bio, Former Head Product Development, Genetech)
Panelist: Wayne Froland (Former Director Complex Manufacturing, Merck)
Panelist: Phil Friedland (Professor Medicine, Hematology and Medical Oncology, Mt. Sinai)
1:40pm // Corporate Presentation - Elpis Biopharmaceuticals
2:00pm // Corporate Presentation - Cumberland Emerging Technologies
2:20pm // Corporate Presentation - MAIA Biotechnology
2:40pm // Corporate Presentation - ODS Medical
3:00pm // Corporate Presentation - pHLIP
3:20pm // Corporate Presentation - Novian Health
3:40pm // Corporate Presentation - TAE Life Sciences
4:00pm // Corporate Presentation - Qu Biologics
4:20pm // Corporate Presentation - Rafael Farma
4:40pm // Corporate Presentation - NaNotics
5:00pm // FIRESIDE CHAT - THERAPEUTIC DEVICES
Moderator: William Werkmeister, Partner, OIP and Advisory Board, NFCR
Amir Jafri, CEO and Founder, Immunicom | Former Director of M&A and R&D, Cardinal Health
Dr. Augusto Bastidas, Founder, International Medical Management Group
5:30pm // CLOSING REMARKS
WEDNESDAY, MARCH 31, 2021
All Times are EST Time Zone
8:50am // OPENING REMARKS
9:00am // TALK - THE NATIONAL CANCER INSTITUTE AS A TECHNOLOGY DEVELOPMENT AND COMMERCIALIZATION PARTNER: IMPACTING PIPELINES AND BOTTOM LINES
Steven Ferguson (Deputy Director and Chair, Licensing and Entrepreneurship | NIH Office of Technology Transfer)
Dr. Michael Salgaller (Supervisor, Invention Development and Marketing Unit, Technology Transfer Center | National Cancer Institute | National
Institutes of Health)
9:30am // Corporate Presentation - PinotBio
9:50am // Corporate Presentation - Oncolize
10:10am // Corporate Presentation - SciTech Development
10:30am // Corporate Presentation - Zilico Limited
10:50am // Corporate Presentation - SignalChem Life Sciences
11:10am // Corporate Presentation - Innova Therapeutics
11:30am // Corporate Presentation - EarlyDiagnostics
11:50am // Corporate Presentation - Tactical Therapeutics
12:10pm // Featured Corporation Presentation - Apricity Health
Dr. Jim Allison (2018 Nobel Laureate | Partner, Apricity)
Dr. Lynda Chin (CEO Apricity | Founder, Department of Genomic Medicine, MD Anderson Cancer Center)
Dr. Pam Sharma (Partner, Apricity | Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson)
Dr. Keith Flaherty (Partner, Apricity | Director of Developmental Therapeutics at the Massachusetts General Hospital Cancer Center | Founder, LOXO
Oncology)
12:40pm // Corporate Presentation - Indi Molecular
1:00pm // Corporate Presentation - Thrive Bioscience
1:20pm // Corporate Presentation - Genomic Expression
1:40pm // Corporate Presentation - Illumacell
2:00pm // Corporate Presentation - International Medical Management Group
2:20pm // Corporate Presentation - Saccharo
2:40pm // Corporate Presentation - Nuview Life Sciences
3:00pm // Corporate Presentation - Alyra Therapeutics
3:20pm // Corporate Presentation - OncoXome
3:40pm // Corporate Presentation - Tradewind BioScience
4:00pm // Corporate Presentation - Tvardi Therapeutics
4:20pm // Corporate Presentation - Adanate
4:40pm // TALK - THE HISTORY AND FUTURE OF GENOMIC TESTING
Priti Hegde (CSO, Foundation Medicine)
5:10pm // CLOSING REMARKS
THURSDAY, APRIL 1, 2021
All Times are EST Time Zone
8:50am // OPENING REMARKS
9:00am // TALK - THE EXPONENTIAL INCORPORATION OF LIQUID BIOPSY IN CANCER THERAPY
Brian Leyland-Jones (Former Director of Emory and McGill Cancer Centers | CMO National Foundation for Cancer Research
Chief Science Officer, The Darwin Foundation)
9:30am // Corporate Presentation - Impact Therapeutics
9:50am // Corporate Presentation - LeadInvent Pharma
10:10am // Corporate Presentation - Jubilant Life Sciences
10:30am // Corporate Presentation - Lightpoint Medical
10:50am // Corporate Presentation - LifeBridge 10000
11:10am // Corporate Presentation - Creatv MicroTech
11:30am // Corporate Presentation - AHEAD Medicine
11:50am // Corporate Presentation - Onconova Therapeutics
12:10pm // WOMEN IN CANCER PANEL
Moderator: Dr. Lynda Chin, Founder, Department of Genomic Medicine, MD Anderson Cancer Center
Panelist: Pam Sharma, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, MD Anderson
Panelist: Sung Poblete, CEO, Stand Up to Cancer
Panelist: Gitte Peterson, CEO of Genomic Expression
12:40om // Corporate Presentation - Promaxo
1:00pm // Corporate Presentation - Ovensa
1:20pm // Corporate Presentation - Kineta
1:40pm // Corporate Presentation -Travera
2:00pm // Corporate Presentation - EhmetHealth
2:20pm // Corporate Presentation - ENB Therapeutics
2:40pm // Corporate Presentation - Summit Biomedical Imaging
3:00pm // Corporate Presentation - Qrono
3:20pm // Corporate Presentation - Geneius Biotechnology
3:40pm // FIRESIDE CHAT
Moderator: William Werkmeister
Participant: Brian Leyland-Jones (Former Director of Emory and McGill Cancer Centers | CMO National Foundation for Cancer Research Chief Science Officer, The Darwin Foundation)
Participant: Ralph Parchment (Managing Director, DCTD Program in Pharmacodynamic Biomarkers, NCI)
4:10pm // CLOSING REMARKS